Key Publications
| Characterisation of the changing genomic landscape of metastatic melanoma using cell free DNA.
Cutts A, Venn O, Dilthey A, Gupta A, Vavoulis D, Dreau H, Middleton M, McVean G, Taylor JC, Schuh A. NPJ Genom Med. 2017 Sep 4;2:25. doi: 10.1038/s41525-017-0030-7. PMID: 29075515 Free PMC article. |
||
| Targeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for Diagnosis.
Kaisaki PJ, Cutts A, Popitsch N, Camps C, Pentony MM, Wilson G, Page S, Kaur K, Vavoulis D, Henderson S, Gupta A, Middleton MR, Karydis I, Talbot DC, Schuh A, Taylor JC. PLoS One. 2016 Sep 14;11(9):e0162809. doi: 10.1371/journal.pone.0162809. eCollection 2016. PMID: 27626278 Free PMC article. |
||
| A statistical approach for tracking clonal dynamics in cancer using longitudinal next-generation sequencing data.
Vavoulis DV, Cutts A, Taylor JC, Schuh A. Bioinformatics. 2020 Jul 28:btaa672. doi: 10.1093/bioinformatics/btaa672. Online ahead of print. PMID: 32722772 |
||
| Clinical-grade validation of whole genome sequencing reveals robust detection of low-frequency variants and copy number alterations in CLL.
Klintman J, Barmpouti K, Knight SJL, Robbe P, Dreau H, Clifford R, Ridout K, Burns A, Timbs A, Bruce D, Antoniou P, Sosinsky A, Becq J, Bentley D, Hillmen P, Taylor JC, Caulfield M, Schuh AH. Br J Haematol. 2018 Aug;182(3):412-417. doi: 10.1111/bjh.15406. Epub 2018 May 29. PMID: 29808933 |
||
| Clinically actionable mutation profiles in patients with cancer identified by whole-genome sequencing.
Schuh A, Dreau H, Knight SJL, Ridout K, Mizani T, Vavoulis D, Colling R, Antoniou P, Kvikstad EM, Pentony MM, Hamblin A, Protheroe A, Parton M, Shah KA, Orosz Z, Athanasou N, Hassan B, Flanagan AM, Ahmed A, Winter S, Harris A, Tomlinson I, Popitsch N, Church D, Taylor JC. Cold Spring Harb Mol Case Stud. 2018 Apr 2;4(2):a002279. doi: 10.1101/mcs.a002279. Print 2018 Apr. PMID: 29610388 Free PMC article. |
||
| Characterisation of the changing genomic landscape of metastatic melanoma using cell free DNA.
Cutts A, Venn O, Dilthey A, Gupta A, Vavoulis D, Dreau H, Middleton M, McVean G, Taylor JC, Schuh A. NPJ Genom Med. 2017 Sep 4;2:25. doi: 10.1038/s41525-017-0030-7. PMID: 29075515 Free PMC article. |
||
| Precision medicine for patients with lymphoma; the Bloodwise Precision Medicine for Aggressive Lymphomas (PMAL) consortium
Bridgin Merron, Shamim Kazmi-Stokes, Thomas Cummin, Sharon Barrans, Shamzah Araf, Koorosh Korfi, Laura D Lopez Pascua, Josh Caddy, Kelly Cozens, Francesco Cucco, Rahman Uddin, Chulin Sha, Reuben Tooze, Gareth Griffiths, Ming Qing Du, Cathy Burton, David Westhead, Jude Fitzgibbon, Anna Schuh, Andrew Davies, Peter Johnson Clinical Medicine Mar 2019, 19 (Suppl 2) 100-101; DOI: 10.7861/clinmedicine.19-2-s100 |
||